Review article · 2025 · Open access

The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases

Min Zhao, Zhao Jiafeng, Huimin Yang, Zirou Ouyang, Chang Lv, Zijun Geng, Jianhong Zhao

Biomedicine & Pharmacotherapy, 188, 118182 · Published 24 May 2025 · DOI 10.1016/j.biopha.2025.118182

Open full textCite this paper

In brief

“The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases” is a 2025 review article by Min Zhao and 6 co-authors, published in Biomedicine & Pharmacotherapy. OpenAlex counts 73 citations as of 21 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY-NC-ND licence: the full text is free to read at Biomedicine & Pharmacotherapy.

Citations
73
Most cited in
2026 (55)
Field-weighted impact
4.71
References
145
Authors
7

Abstract

Bile acids are a family of signaling molecules synthesized in the liver and metabolized by gut bacteria. As metabolites of the intestinal microbiota, bile acids bind to various receptors, and affect the metabolism and immune function of the host, including glucose and lipid metabolism, energy homeostasis, and inflammatory response. Conversely, bile acids also shape the composition of the gut microbiota. Given their critical role in physiological regulation, disrupted bile acid signaling is closely linked to metabolic diseases. Consequently, therapeutic strategies targeting bile acids are increasingly being explored. The size, composition, and function of the bile acid pool can be modulated through direct treatments (e.g., bile acid replacement therapy, administration of bile acid receptor agonists/antagonists) or indirect treatments (e.g., gut microbiota modulation, probiotic supplementation), providing new ideas for preventing and treating metabolic diseases.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Zhao, M., Jiafeng, Z., Yang, H., Ouyang, Z., Lv, C., Geng, Z., & Zhao, J. (2025). The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases. Biomedicine & Pharmacotherapy, 188, 118182. https://doi.org/10.1016/j.biopha.2025.118182

MLA 9

Zhao, Min, et al. “The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases.” Biomedicine & Pharmacotherapy, vol. 188, 2025, p. 118182. https://doi.org/10.1016/j.biopha.2025.118182.

Chicago

Zhao, Min, Zhao Jiafeng, Huimin Yang, Zirou Ouyang, Chang Lv, Zijun Geng, and Jianhong Zhao. 2025. “The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases.” Biomedicine & Pharmacotherapy 188: 118182. https://doi.org/10.1016/j.biopha.2025.118182.

Harvard

Zhao, M. et al. (2025) ‘The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases’, Biomedicine & Pharmacotherapy, 188, p. 118182. doi:10.1016/j.biopha.2025.118182.

IEEE

M. Zhao et al., “The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases,” Biomedicine & Pharmacotherapy, vol. 188, p. 118182, 2025, doi: 10.1016/j.biopha.2025.118182.

BibTeX

@article{zhao2025bile,
  title     = {{The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases}},
  author    = {Zhao, Min and Jiafeng, Zhao and Yang, Huimin and Ouyang, Zirou and Lv, Chang and Geng, Zijun and Zhao, Jianhong},
  journal   = {Biomedicine \& Pharmacotherapy},
  year      = {2025},
  volume    = {188},
  pages     = {118182},
  doi       = {10.1016/j.biopha.2025.118182},
  url       = {https://doi.org/10.1016/j.biopha.2025.118182}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health

  • bile acids
  • gut microbiota
  • bile acid signaling
  • bile acid receptors
  • bile acid receptor agonists
  • probiotics
  • gut microbiota modulation
  • glucose metabolism

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Zhao, M., Jiafeng, Z., Yang, H., Ouyang, Z., Lv, C., Geng, Z., & Zhao, J. (2025). The bile acid-gut microbiota axis: A central hub for physiological regulation and a novel therapeutic target for metabolic diseases. Biomedicine & Pharmacotherapy, 188, 118182. https://doi.org/10.1016/j.biopha.2025.118182

How many times has this paper been cited?

73 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Biomedicine & Pharmacotherapy: sign in and open the full text from this page.

Who wrote this paper?

Min Zhao, Zhao Jiafeng, Huimin Yang, Zirou Ouyang, Chang Lv, Zijun Geng, Jianhong Zhao.

What is the DOI of this paper?

10.1016/j.biopha.2025.118182, permanently at https://doi.org/10.1016/j.biopha.2025.118182. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.